Recent Finacing
Recent Raise
CV6 Therapeutics is a drug-development biotech developing small-molecule cancer and inflammatory therapeutics, advancing lead CV6-168 into first-in-human Phase 1a trials after preclinical completion and pursuing CV6-1271.
